BACKGROUND: In patients with head and neck cancer, radiation treatment (RT) is a risk factor for hypothyroidism. However, the specific magnitude of risk after RT in older patients is not known. METHODS: We identified 5916 patients (age > 65 years) from SEER-Medicare diagnosed with head and neck cancer from 1992 to 2002. Proportional hazards models compared hypothyroidism risk after any RT versus surgery alone. RESULTS: In patients treated with RT, 5-year incidence of hypothyroidism was 20% and 10-year incidence was 59%; in patients treated with surgery alone, incidence was 7% and 39% (p < .001). Patients treated with RT had increased adjusted risk (hazard ratio [HR] = 2.14; 95% confidence interval [CI] = 1.74-2.62), persisting for up to 10 years of follow-up (HR = 1.85, 95% CI = 1.39-2.44 from 5 to 10 years). CONCLUSION: In older patients with head and neck cancer, RT is associated with elevated hypothyroidism risk. As onset may be delayed for years, patients may require lifelong thyroid function screening after treatment. Copyright 2009 Wiley Periodicals, Inc.
BACKGROUND: In patients with head and neck cancer, radiation treatment (RT) is a risk factor for hypothyroidism. However, the specific magnitude of risk after RT in older patients is not known. METHODS: We identified 5916 patients (age > 65 years) from SEER-Medicare diagnosed with head and neck cancer from 1992 to 2002. Proportional hazards models compared hypothyroidism risk after any RT versus surgery alone. RESULTS: In patients treated with RT, 5-year incidence of hypothyroidism was 20% and 10-year incidence was 59%; in patients treated with surgery alone, incidence was 7% and 39% (p < .001). Patients treated with RT had increased adjusted risk (hazard ratio [HR] = 2.14; 95% confidence interval [CI] = 1.74-2.62), persisting for up to 10 years of follow-up (HR = 1.85, 95% CI = 1.39-2.44 from 5 to 10 years). CONCLUSION: In older patients with head and neck cancer, RT is associated with elevated hypothyroidism risk. As onset may be delayed for years, patients may require lifelong thyroid function screening after treatment. Copyright 2009 Wiley Periodicals, Inc.
Authors: Chelsea C Pinnix; Laura Cella; Therese Y Andraos; Zeina Ayoub; Sarah A Milgrom; Jillian Gunther; Sonali Thosani; Christine Wogan; Manuel Conson; Vittoria D'Avino; Yasuhiro Oki; Michelle Fanale; Hun J Lee; Sattva Neelapu; Luis Fayad; Frederick Hagemeister; M Alma Rodriguez; Loretta J Nastoupil; Yago Nieto; Wei Qiao; Roberto Pacelli; Bouthaina Dabaja Journal: Int J Radiat Oncol Biol Phys Date: 2018-03-14 Impact factor: 7.038
Authors: Jared Gershowitz; Hann-Hsiang Chao; Abigail Doucette; John N Lukens; Samuel Swisher-McClure; Gregory S Weinstein; Bert W O'Malley; Ara A Chalian; Christopher H Rassekh; Jason G Newman; Roger B Cohen; Joshua M Bauml; Charu Aggarwal; Alexander Lin Journal: Br J Radiol Date: 2019-10-15 Impact factor: 3.039
Authors: Suleiman I Al Ashi; Bicky Thapa; Monica Flores; Ramsha Ahmed; Shab E Gul Rahim; Maryam Amir; Mohammad Alomari; Pravallika Chadalavada; Shannon L Morrison; James F Bena; Aleck Hercbergs; Ossama Lashin; Hamed Daw Journal: J Endocr Soc Date: 2021-06-01
Authors: Marcus M Monroe; Luke O Buchmann; Jason P Hunt; Ying J Hitchcock; Shane Lloyd; Mia Hashibe Journal: Laryngoscope Investig Otolaryngol Date: 2017-02-02
Authors: Bernhard J Jank; Markus Haas; Julia Schnoell; Michaela Schlederer; Gregor Heiduschka; Lukas Kenner; Lorenz Kadletz-Wanke Journal: J Pers Med Date: 2021-12-08
Authors: Alexander Lin; John H C Chang; Ryan S Grover; Frank J P Hoebers; Upendra Parvathaneni; Samir H Patel; Juliette Thariat; David J Thomson; Johannes A Langendijk; Steven J Frank Journal: Int J Part Ther Date: 2021-06-25